Abstract

Migraine: A General Approach to Prevention and Treatment

Author(s): Kennedy Bonnie M

Issue: Sep/Oct 2006 - Dermatology

Page(s): 344-350

Download in electronic PDF format for $75

Abstract

Migraines occasionally are a symptom of another serious underlying health condition. Therefore, it is important for pharmacists to be familiar with the diagnostic criteria of migraine so that they can recognize which patients warrant a referral to a healthcare provider for further evaluation. Criteria for the diagnosis of migraines have been established by the International Headache Society. To assist migraine sufferers in their efforts to find relief from the pain and reduce the occurrence of migraines, it is important that compounding pharmacists be aware of the clinical features of migraine such as the four phases, the pathophysiology of migraines, the drug classes commonly used in the treatment of migraines, the variety of therapeutic approaches, and treatment options that may be offered by compounding pharmacists.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Sep/Oct 2006 Pg. 344-350	Migraine: A General Approach to Prevention and Treatment Author(s): Kennedy Bonnie M
Jul/Aug 2012 Pg. 270-274	A Concise Discussion of Headache Types, Part 3: Migraine Author(s): Williams LaVonn A, Allen Loyd V Jr
May/Jun 2010 Pg. 182-192	Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Jul/Aug 2014 Pg. 278-286	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jul/Aug 2015 Pg. 295-300	Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Mar/Apr 2024 Pg. 100-109	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Mar/Apr 2024 Pg. 111-116	Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
May/Jun 2007 Pg. 200	Case Report: Ketoprofen/Riboflavin/Caffeine Capsules and Progesterone Therapy for Recurrent Migraine Pain Author(s): Fields Shannon W
May/Jun 2010 Pg. 200-203	Topical Medications for Orofacial Neuropathic Pain Author(s): Bramwell Bethany L
Mar/Apr 2016 Pg. 147	Sumatriptan 5-mg or 20-mg per 100-μL Nasal Spray Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 250-256	Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives Author(s): Trimble John, Light Bob
Mar/Apr 2016 Pg. 107-113	Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future Author(s): Rabi Joseph
Jul/Aug 2020 Pg. 320	Sumatriptan, Lidocaine Hydrochloride, Dexamethasone, Pentoxifylline, and Ibuprofen Transdermal Cream (Migraine Cream) Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 182-188	A Concise Discussion of Headache Types, Part 2: Migraine Author(s): Williams LaVonn A
Jul/Aug 2003 Pg. 266-270	Sensitization Therapy for Warts Author(s): Kuntz Rachael
Mar/Apr 2006 Pg. 159-160	PostScription: Treatment of Chronic Pain with Methadone or Levorphanol Author(s): McNulty Jack P
May/Jun 2007 Pg. 212-218	Levorphanol for Excruciating Pain from Oral Cancer: A Case Report Author(s): McNulty Jack P
May/Jun 2023 Pg. 237	Migraine Headache Suppositories Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 14-19	Using Compounded Medications for the Topical Treatment of Complex Regional Pain Syndrome Type I Following Trauma: A Case Report Author(s): Zur Eyal
Jul/Aug 2003 Pg. 272-275	Effectiveness in Oral Rhus toxicodendron Solution for Poison Ivy Prevention Author(s): Stein Michael F, Parsons Eric